The Diagnostic Genomics Laboratory at Indiana University School of Medicine is a newly established genomics laboratory under the auspices of the Genetic Testing Laboratories in the Department of Medical and Molecular Genetics Division of Diagnostic Genomics. The Diagnostic Genomics Laboratory provides competitive clinical somatic (cancer) and germline genomics testing services to IU Health and state of Indiana. Enabled by state-of-the-art next generation sequencing (NGS) technology and advanced bioinformatic infrastructure, the lab currently offers a disease-targeted NGS panel testing (somatic/cancer) for plasma cell myeloma (also known as multiple myeloma), and will soon be offering clinical genome and clinical exome diagnostic testing.